GO
| HSI1 | 25,935.41 | -16.99 | 238.82B |
| HSCEI1 | 9,163.24 | -9.97 | 79.37B |
| Back Zoom + Zoom - Block Traded | |
|
2025-11-05 11:15:29 Citi Research issued a research report opening a 30-day positive catalyst watch on MAOYAN ENT (01896.HK), driven by the scheduled release of the key animated movie Demon Slayer on 14 November, with MAOYAN ENT being its distributor. The movie has already demonstrated robust global box office performance, ranking fifth worldwide as of yesterday with over US$677 million, and becoming the top international movie in North America. Its announcement has generated significant popularity, evidenced by Maoyan Pro recording over 400,000 ‘to-watch’ clicks within a single day. With the New Year holiday period commencing in late November, Citi Research also predicted that any box office outperformance will serve as a positive catalyst for MAOYAN ENT as the largest ticketing platform. Therefore, the broker kept rating at Buy for MAOYAN ENT, with a target price of $9.3, based on a 14x adjusted EPS for 2026. ~ AAStocks Financial News Website: www.aastocks.com | |